Loading…
Reported covered position: Chief Counsel - Senator Dianne Feinstein, Minority Chief Counsel and Staff Director, Subcommittee on Technology, Terrorism and Government Information, Senate Judiciary Committee, Counsel, Senator Dianne Feinstein
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Restoring Access to Medication and Improving Health Savings Act of 2016
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S.709 - Restoring Access to Medication Act H.R.1270 - Restoring Access to Medication Act
Restoring Access to Medication and Improving Health Savings Act of 2016
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
OASIS HOLDINGS LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · first_quarter · Q1
EB-5 Project
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER INC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · first_quarter · 1A
Source: Senate LDA
| VIIAD SYSTEMS, LLC |
| 5 |
| 2016 |
| OASIS HOLDINGS, LLC | 4 | 2016–2017 |
| BIOTECHNOLOGY INDUSTRY ORGANIZATION | 1 | 2016 |
| JOHNSON & JOHNSON SERVICES, INC. | 1 | 2016 |
S.709 - Restoring Access to Medication Act H.R.1270 - Restoring Access to Medication Act
Restoring Access to Medication and Improving Health Savings Act of 2016
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S.709 - Restoring Access to Medication Act H.R.1270 - Restoring Access to Medication Act
Restoring Access to Medication and Improving Health Savings Act of 2016
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S.709 - Restoring Access to Medication Act H.R.1270 - Restoring Access to Medication Act
National Defense Authorization Act for Fiscal Year 2017
Client: SAFE RX · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Educating policy makers about anti-pilfering technology known as locking prescription vials (LPVs) Issues relating to establishing a pilot program for LPVs Issues relating to DEA's authority to regulate dispensing Schedule II-IV drugs S. 524/H.R. 953 - Comprehensive Addiction and Recovery Act of 2016 S. 2943/H.R. 4909 - National Defense Authorization Act for fiscal year 2017
National Defense Authorization Act for Fiscal Year 2017
Client: SAFE RX · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Educating policy makers about anti-pilfering technology known as locking prescription vials (LPVs) Issues relating to establishing a pilot program for LPVs Issues relating to DEA's authority to regulate dispensing Schedule II-IV drugs S. 524/H.R. 953 - Comprehensive Addiction and Recovery Act of 2016 S. 2943/H.R. 4909 - National Defense Authorization Act for fiscal year 2017
National Defense Authorization Act for Fiscal Year 2017
Client: SAFE RX · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Educating policy makers about anti-pilfering technology known as locking prescription vials (LPVs) Issues relating to establishing a pilot program for LPVs Issues relating to DEA's authority to regulate dispensing Schedule II-IV drugs S. 524/H.R. 953 (PL 114-328) Comprehensive Addiction and Recovery Act of 2016 - Title VII, Section 746 Department of Defense Study on preventing the diversion of opiod medications S. 2943/H.R. 4909 (PL 114-198) National Defense Authorization Act for fiscal year 2017 - Title III, Section 301 Evidence based prescription opiod and heroin treatment and interventions demonstration
Restoration of America's Wire Act
Client: CAESARS ENTERPRISE SERVICES, LLC · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Internet gaming issues H.R. 707-Restoration of America's Wire Act S.1668-Restoration of America's Wire Act
Restoration of America's Wire Act
Client: CAESARS ENTERPRISE SERVICES, LLC · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Internet gaming issues H.R. 707-Restoration of America's Wire Act S.1668-Restoration of America's Wire Act
Restoration of America's Wire Act
Client: CAESARS ENTERPRISE SERVICES, LLC · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Internet gaming issues H.R. 707-Restoration of America's Wire Act S.1668-Restoration of America's Wire Act
Restoration of America's Wire Act
Client: CAESARS ENTERPRISE SERVICES, LLC · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Internet gaming issues H.R. 707-Restoration of America's Wire Act S.1668-Restoration of America's Wire Act
Restoration of America's Wire Act
Client: CAESARS ENTERPRISE SERVICES, LLC · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Internet gaming issues H.R. 707-Restoration of America's Wire Act S.1668-Restoration of America's Wire Act
Restoration of America's Wire Act
Client: CAESARS ENTERPRISE SERVICES, LLC · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Internet gaming issues H.R. 707-Restoration of America's Wire Act S.1668-Restoration of America's Wire Act
Innovation Act
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
H.R.9 - Innovation Act S.1137 - PATENT Act
Comprehensive Addiction and Recovery Act of 2015
Client: SAFE RX · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Educating policy makers about anti-pilfering technology known as locking prescription vials (LPVs) Issues relating to establishing a pilot program for LPVs Issues relating to DEA's authority to regulate dispensing Schedule II-IV drugs S. 524/H.R. 953 - Comprehensive Addiction and Recovery Act of 2016 S. 2943/H.R. 4909 - National Defense Authorization Act for fiscal year 2017
Comprehensive Addiction and Recovery Act of 2015
Client: SAFE RX · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Educating policy makers about anti-pilfering technology known as locking prescription vials (LPVs) Issues relating to establishing a pilot program for LPVs Issues relating to DEA's authority to regulate dispensing Schedule II-IV drugs S. 524/H.R. 953 - Comprehensive Addiction and Recovery Act of 2016 S. 2943/H.R. 4909 - National Defense Authorization Act for fiscal year 2017
Comprehensive Addiction and Recovery Act of 2015
Client: SAFE RX · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Educating policy makers about anti-pilfering technology known as locking prescription vials (LPVs) Issues relating to establishing a pilot program for LPVs Issues relating to DEA's authority to regulate dispensing Schedule II-IV drugs S. 524/H.R. 953 (PL 114-328) Comprehensive Addiction and Recovery Act of 2016 - Title VII, Section 746 Department of Defense Study on preventing the diversion of opiod medications S. 2943/H.R. 4909 (PL 114-198) National Defense Authorization Act for fiscal year 2017 - Title III, Section 301 Evidence based prescription opiod and heroin treatment and interventions demonstration
PATENT Act
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
H.R.9 - Innovation Act S.1137 - PATENT Act
Restoration of America's Wire Act
Client: CAESARS ENTERPRISE SERVICES, LLC · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Internet gaming issues H.R. 707-Restoration of America's Wire Act S.1668-Restoration of America's Wire Act
Restoration of America's Wire Act
Client: CAESARS ENTERPRISE SERVICES, LLC · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Internet gaming issues H.R. 707-Restoration of America's Wire Act S.1668-Restoration of America's Wire Act
Restoration of America's Wire Act
Client: CAESARS ENTERPRISE SERVICES, LLC · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Internet gaming issues H.R. 707-Restoration of America's Wire Act S.1668-Restoration of America's Wire Act
Restoration of America's Wire Act
Client: CAESARS ENTERPRISE SERVICES, LLC · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Internet gaming issues H.R. 707-Restoration of America's Wire Act S.1668-Restoration of America's Wire Act
Restoration of America's Wire Act
Client: CAESARS ENTERPRISE SERVICES, LLC · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Internet gaming issues H.R. 707-Restoration of America's Wire Act S.1668-Restoration of America's Wire Act
Restoration of America's Wire Act
Client: CAESARS ENTERPRISE SERVICES, LLC · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Internet gaming issues H.R. 707-Restoration of America's Wire Act S.1668-Restoration of America's Wire Act
National Defense Authorization Act for Fiscal Year 2017
Client: SAFE RX · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Educating policy makers about anti-pilfering technology known as locking prescription vials (LPVs) Issues relating to establishing a pilot program for LPVs Issues relating to DEA's authority to regulate dispensing Schedule II-IV drugs S. 524/H.R. 953 - Comprehensive Addiction and Recovery Act of 2016 S. 2943/H.R. 4909 - National Defense Authorization Act for fiscal year 2017
National Defense Authorization Act for Fiscal Year 2017
Client: SAFE RX · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Educating policy makers about anti-pilfering technology known as locking prescription vials (LPVs) Issues relating to establishing a pilot program for LPVs Issues relating to DEA's authority to regulate dispensing Schedule II-IV drugs S. 524/H.R. 953 - Comprehensive Addiction and Recovery Act of 2016 S. 2943/H.R. 4909 - National Defense Authorization Act for fiscal year 2017
National Defense Authorization Act for Fiscal Year 2017
Client: SAFE RX · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Educating policy makers about anti-pilfering technology known as locking prescription vials (LPVs) Issues relating to establishing a pilot program for LPVs Issues relating to DEA's authority to regulate dispensing Schedule II-IV drugs S. 524/H.R. 953 (PL 114-328) Comprehensive Addiction and Recovery Act of 2016 - Title VII, Section 746 Department of Defense Study on preventing the diversion of opiod medications S. 2943/H.R. 4909 (PL 114-198) National Defense Authorization Act for fiscal year 2017 - Title III, Section 301 Evidence based prescription opiod and heroin treatment and interventions demonstration
Comprehensive Addiction and Recovery Act of 2016
Client: SAFE RX · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Educating policy makers about anti-pilfering technology known as locking prescription vials (LPVs) Issues relating to establishing a pilot program for LPVs Issues relating to DEA's authority to regulate dispensing Schedule II-IV drugs S. 524/H.R. 953 - Comprehensive Addiction and Recovery Act of 2016 S. 2943/H.R. 4909 - National Defense Authorization Act for fiscal year 2017
Comprehensive Addiction and Recovery Act of 2016
Client: SAFE RX · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Educating policy makers about anti-pilfering technology known as locking prescription vials (LPVs) Issues relating to establishing a pilot program for LPVs Issues relating to DEA's authority to regulate dispensing Schedule II-IV drugs S. 524/H.R. 953 - Comprehensive Addiction and Recovery Act of 2016 S. 2943/H.R. 4909 - National Defense Authorization Act for fiscal year 2017
Comprehensive Addiction and Recovery Act of 2016
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Preserving consumer access to over-the-counter medicines containing pseudoephedrine Rx-to-OTC switch Issues related to monograph reform S. 524 - Comprehensive Addiction and Recovery Act of 2016
Comprehensive Addiction and Recovery Act of 2016
Client: SAFE RX · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Educating policy makers about anti-pilfering technology known as locking prescription vials (LPVs) Issues relating to establishing a pilot program for LPVs Issues relating to DEA's authority to regulate dispensing Schedule II-IV drugs S. 524/H.R. 953 (PL 114-328) Comprehensive Addiction and Recovery Act of 2016 - Title VII, Section 746 Department of Defense Study on preventing the diversion of opiod medications S. 2943/H.R. 4909 (PL 114-198) National Defense Authorization Act for fiscal year 2017 - Title III, Section 301 Evidence based prescription opiod and heroin treatment and interventions demonstration
Comprehensive Addiction and Recovery Act of 2016
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Preserving consumer access to over-the-counter medicines containing pseudoephedrine Rx-to-OTC switch Issues related to monograph reform S. 524 - Comprehensive Addiction and Recovery Act of 2016
Comprehensive Addiction and Recovery Act of 2016
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Preserving consumer access to over-the-counter medicines containing pseudoephedrine Rx-to-OTC switch Issues related to monograph reform The Microbead-Free Waters Act of 2015 S. 524 - Comprehensive Addiction and Recovery Act of 2016
Restoring Access to Medication Act of 2015
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S.709 - Restoring Access to Medication Act H.R.1270 - Restoring Access to Medication Act
Restoring Access to Medication Act of 2015
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S.709 - Restoring Access to Medication Act H.R.1270 - Restoring Access to Medication Act
Restoring Access to Medication Act of 2015
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S.709 - Restoring Access to Medication Act H.R.1270 - Restoring Access to Medication Act
Restoring Access to Medication Act of 2015
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S.709 - Restoring Access to Medication Act H.R.1270 - Restoring Access to Medication Act
Restoring Access to Medication and Improving Health Savings Act of 2016
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S.709 - Restoring Access to Medication Act H.R.1270 - Restoring Access to Medication Act
Restoring Access to Medication and Improving Health Savings Act of 2016
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S.709 - Restoring Access to Medication Act H.R.1270 - Restoring Access to Medication Act
Restoration of America's Wire Act
Client: CAESARS ENTERPRISE SERVICES, LLC · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Internet gaming issues H.R. 707-Restoration of America's Wire Act S.1668-Restoration of America's Wire Act
Restoration of America's Wire Act
Client: CAESARS ENTERPRISE SERVICES, LLC · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Internet gaming issues H.R. 707-Restoration of America's Wire Act S.1668-Restoration of America's Wire Act
Restoring Access to Medication Act of 2015
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S.709 - Restoring Access to Medication Act H.R.1270 - Restoring Access to Medication Act
Restoring Access to Medication Act of 2015
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S.709 - Restoring Access to Medication Act H.R.1270 - Restoring Access to Medication Act
Antitrust issues associated with proposed merger between Pfizer and Allergan
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHNSON & JOHNSON SERVICES, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · fourth_quarter · Q4
Issues related to contact lens pricing Issues related to pseudoephedrine Issues related to the regulation of cosmetic products Safe use of OTC products Matters related to American Medical Association Resolution 208(A-16) adopted April 2016
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Agency for International Development (USAID), White House Office
OASIS HOLDINGS LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · fourth_quarter · Q4
EB-5 Project
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MANAGEMENT AND TRAINING CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · fourth_quarter · Q4
Issues related to the Department of Justice's August 18, 2016, directive to reduce the use of private prisons
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIIAD SYSTEMS, LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · fourth_quarter · 4A
Issues related to health care technology
SAFE RX via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · fourth_quarter · Q4
Educating policy makers about anti-pilfering technology known as locking prescription vials (LPVs) Issues relating to establishing a pilot program for LPVs Issues relating to DEA's authority to regulate dispensing Schedule II-IV drugs S. 524/H.R. 953 (PL 114-328) Comprehensive Addiction and Recovery Act of 2016 - Title VII, Section 746 Department of Defense Study on preventing the diversion of opiod medications S. 2943/H.R. 4909 (PL 114-198) National Defense Authorization Act for fiscal year 2017 - Title III, Section 301 Evidence based prescription opiod and heroin treatment and interventions demonstration
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · fourth_quarter · Q4
Preserving consumer access to over-the-counter medicines containing pseudoephedrine Rx-to-OTC switch Issues related to monograph reform
Dietary supplement ingredient issues
Dextromethorphan Legislation related to reducing incidents of abuse of a common ingredient in over-the-counter cough and cold medications
CAESARS ENTERPRISE SERVICES, LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · fourth_quarter · Q4
Internet gaming issues H.R. 707-Restoration of America's Wire Act S.1668-Restoration of America's Wire Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAESARS ENTERPRISE SERVICES, LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · third_quarter · 3A
Internet gaming issues H.R. 707-Restoration of America's Wire Act S.1668-Restoration of America's Wire Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRENTWOOD SCHOOL via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · third_quarter · 3T
VA Lease Issue
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
VIIAD SYSTEMS, LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · fourth_quarter · Q4
Issues related to health care technology
CAESARS ENTERPRISE SERVICES, LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · third_quarter · 3A
Internet gaming issues H.R. 707-Restoration of America's Wire Act S.1668-Restoration of America's Wire Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MANAGEMENT AND TRAINING CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · third_quarter · 3A
Issues related to the Department of Justice's private prisons decision regarding federal contracts for prisons
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MANAGEMENT AND TRAINING CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · third_quarter · 3A
Issues related to the Department of Justice's private prisons decision regarding federal contracts for prisons
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MANAGEMENT AND TRAINING CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · third_quarter · RA
Issues related to the Department of Justice's private prisons decision regarding federal contracts for prisions
OASIS HOLDINGS LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · third_quarter · Q3
EB-5 Project
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAFE RX via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · third_quarter · Q3
Educating policy makers about anti-pilfering technology known as locking prescription vials (LPVs) Issues relating to establishing a pilot program for LPVs Issues relating to DEA's authority to regulate dispensing Schedule II-IV drugs S. 524/H.R. 953 - Comprehensive Addiction and Recovery Act of 2016 S. 2943/H.R. 4909 - National Defense Authorization Act for fiscal year 2017
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · third_quarter · Q3
Dextromethorphan Legislation related to reducing incidents of abuse of a common ingredient in over-the-counter cough and cold medications
Preserving consumer access to over-the-counter medicines containing pseudoephedrine Rx-to-OTC switch Issues related to monograph reform S. 524 - Comprehensive Addiction and Recovery Act of 2016
S.709 - Restoring Access to Medication Act H.R.1270 - Restoring Access to Medication Act
BRENTWOOD SCHOOL via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · third_quarter · Q3
VA Lease Issue
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
MANAGEMENT AND TRAINING CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · third_quarter · Q3
Issues related to the Department of Justice's private prisons decision regarding federal contracts for prisons
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAESARS ENTERPRISE SERVICES, LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · third_quarter · Q3
Internet gaming issues H.R. 707-Restoration of America's Wire Act S.1668-Restoration of America's Wire Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIIAD SYSTEMS, LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · third_quarter · Q3
Issues related to health care technology
Filing targets: Indian Health Service
MANAGEMENT AND TRAINING CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · third_quarter · RR
Issues related to the Department of Justice's private prisons decision regarding federal contracts for prisions
CAESARS ENTERPRISE SERVICES, LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · second_quarter · Q2
Internet gaming issues H.R. 707-Restoration of America's Wire Act S.1668-Restoration of America's Wire Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · second_quarter · Q2
Dietary supplement ingredient issues
Preserving consumer access to over-the-counter medicines containing pseudoephedrine Rx-to-OTC switch Issues related to monograph reform S. 524 - Comprehensive Addiction and Recovery Act of 2016
S.709 - Restoring Access to Medication Act H.R.1270 - Restoring Access to Medication Act
BIOTECHNOLOGY INDUSTRY ORGANIZATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · second_quarter · 2T
H.R.9 - Innovation Act S.1137 - PATENT Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIIAD SYSTEMS, LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · second_quarter · Q2
Issues related to health care technology
Filing targets: U.S. Immigration & Customs Enforcement (ICE)
SAFE RX via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · second_quarter · Q2
Educating policy makers about anti-pilfering technology known as locking prescription vials (LPVs) Issues relating to establishing a pilot program for LPVs Issues relating to DEA's authority to regulate dispensing Schedule II-IV drugs S. 524/H.R. 953 - Comprehensive Addiction and Recovery Act of 2016 S. 2943/H.R. 4909 - National Defense Authorization Act for fiscal year 2017
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
BRENTWOOD SCHOOL via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · second_quarter · Q2
VA Lease Issue
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
OASIS HOLDINGS LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · second_quarter · Q2
EB-5 Project
Filing targets: HOUSE OF REPRESENTATIVES
PFIZER INC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · second_quarter · 2T
Antitrust issues associated with proposed merger between Pfizer and Allergan
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIIAD SYSTEMS, LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · first_quarter · Q1
Issues related to health care technology
Filing targets: U.S. Immigration & Customs Enforcement (ICE)
SAFE RX via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · first_quarter · Q1
Educating policy makers about anti-pilfering technology known as locking prescription vials (LPVs) Issues relating to establishing a pilot program for LPVs Issues relating to DEA's authority to regulate dispensing Schedule II-IV drugs
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
PFIZER INC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · first_quarter · Q1
Antitrust issues associated with proposed merger between Pfizer and Allergan
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRENTWOOD SCHOOL via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · first_quarter · Q1
VA Lease Issue
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · first_quarter · Q1
Dietary supplement ingredient issues
Dextromethorphan Legislation related to reducing incidents of abuse of a common ingredient in over-the-counter cough and cold medications
Preserving consumer access to over-the-counter medicines containing pseudoephedrine Rx-to-OTC switch Issues related to monograph reform The Microbead-Free Waters Act of 2015 S. 524 - Comprehensive Addiction and Recovery Act of 2016
CAESARS ENTERPRISE SERVICES, LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · first_quarter · Q1
Internet gaming issues H.R. 707-Restoration of America's Wire Act S.1668-Restoration of America's Wire Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAFE RX via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2016 · first_quarter · RR
Use of lockable prescription vials for controlled substances in Schedules II-IV
PFIZER INC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2015 · fourth_quarter · 4A
Antitrust issues associated with proposed merger between Pfizer and Allergan
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2015 · fourth_quarter · 4A
S.709 - Restoring Access to Medication Act H.R.1270 - Restoring Access to Medication Act
Dextromethorphan Legislation related to reducing incidents of abuse of a common ingredient in over-the-counter cough and cold medications
Preserving consumer access to over-the-counter medicines containing pseudoephedrine Rx-to-OTC switch Issues related to monograph reform The Microbead-Free Waters Act of 2015
PFIZER INC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2015 · fourth_quarter · Q4
Antitrust issues associated with proposed merger between Pfizer and Allergan
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2015 · fourth_quarter · Q4
Dextromethorphan Legislation related to reducing incidents of abuse of a common ingredient in over-the-counter cough and cold medications
S.709 - Restoring Access to Medication Act H.R.1270 - Restoring Access to Medication Act
Preserving consumer access to over-the-counter medicines containing pseudoephedrine Rx-to-OTC switch Issues related to monograph reform The Microbead-Free Waters Act of 2015
CAESARS ENTERPRISE SERVICES, LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2015 · fourth_quarter · Q4
Internet gaming issues H.R. 707-Restoration of America's Wire Act S.1668-Restoration of America's Wire Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRENTWOOD SCHOOL via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2015 · fourth_quarter · Q4
VA Lease Issue
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
PFIZER INC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2015 · fourth_quarter · RA
Antitrust issues associated with proposed merger between Pfizer and Allergan
S.709 - Restoring Access to Medication Act H.R.1270 - Restoring Access to Medication Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Dietary supplement ingredient issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Dextromethorphan Legislation related to reducing incidents of abuse of a common ingredient in over-the-counter cough and cold medications
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S.709 - Restoring Access to Medication Act H.R.1270 - Restoring Access to Medication Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Dietary supplement ingredient issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Dietary supplement ingredient issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE